The possession of a hypodermic syringe or needle by a consumer who participates in, or an employee or volunteer of, a sterile syringe access program established pursuant to sections 3 and 4 of P.L. 2006, c. 99(C.26:5C-27 and C.26:5C-28), as amended by P.L. 2016, c. 36, shall not constitute an offense pursuant toet seq. This provision shall extend to a hypodermic syringe or needle that contains a residual amount of a controlled dangerous substance or controlled substance analog.
N.J.S. § 2C:36-6a